CompoAtlas

Digestive enzymes + probiotic

Food supplement declared in France, decision dated 23 July 2025

Digestive enzymes + probiotic (Osavi) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Osavi
Food business operator placing the product on the market
Olivit Sp. z o.o.
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
1 gélule
Intended populations
Hommes et femmes de 18 ans et plus
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Enfants (de moins de 10 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Digestion

Declaration 334778, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Substances

NamePer day
papaïne150 mg
bromélaïne60 mg
lactase30.5 mg
amylase11.8 mg
protéase6 mg
cellulase2.9 mg
lipase0.2 mg

Other active ingredients

NamePer day
Inulinenot declared

Micro-organisms

StrainPer day
Bacillus Coagulans MTCC 58562 (unit not declared)

Additives

E464

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Osavi

Enter to analyse, Shift+Enter for a new line